Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets.

Ononye, S N; Shi, W; Wali, V B; Aktas, B; Jiang, T; Hatzis, C; Pusztai, L

Ononye, S N; Shi, W; Wali, V B; Aktas, B; Jiang, T; Hatzis, C; Pusztai, L.

Affiliation

Ononye SN; Yale Cancer Center, Yale School of Medicine, New Haven, CT, 06511, USA, sophia.ononye@yale.edu.

Breast Cancer Res Treat ; 148(3): 477-88, 2014 Dec.

Article in En | MEDLINE | ID: mdl-25395317

Subject(s)

Isoenzymes/biosynthesis; Metabolic Networks and Pathways/genetics; Molecular Targeted Therapy; Neoplasms/genetics; Databases, Protein; Energy Metabolism/drug effects; Energy Metabolism/genetics; Enzyme Inhibitors/therapeutic use; Gene Expression Regulation, Neoplastic; Glycolysis/genetics; Humans; Isoenzymes/antagonists & inhibitors; Isoenzymes/metabolism; Metabolic Networks and Pathways/drug effects; Neoplasms/pathology; Neoplasms/therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metabolic Networks and Pathways / Molecular Targeted Therapy / Isoenzymes / Neoplasms Limits: Humans Language: En Journal: Breast Cancer Res Treat Year: 2014 Document type: Article Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google